Oregon OR
Eli Lilly releases more data for new obesity drug, moving toward fast-track approval
In the summer of 2022, just as the hoopla surrounding the diabetes and weight loss drugs Ozempic and Wegovy was rising, doctors were surprised to see clinical trial results of a si…
